18:06 EST Milestone Pharmaceuticals (MIST) trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIST:
- Milestone Pharmaceuticals: Buy Rating Reaffirmed Amid Imminent PDUFA Date and Misunderstood CRL Implications
- Milestone Pharmaceuticals Reports Q3 2025 Financial Results
- Milestone Pharmaceuticals Prepares for CARDAMYST Launch Amid Financial Growth
- Milestone Pharmaceuticals: Positioned for Success with Cardamyst’s Potential Approval and Launch
- Milestone Pharmaceuticals reports Q3 EPS (12c), consensus (17c)